跳至主要内容
临床试验/NCT02243644
NCT02243644已完成3 期

A Clinical Trial to Study the Effects of Two Different Duration of Same Drug Albendazole in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Scan Head at the End of 6 Months

All India Institute of Medical Sciences, New Delhi1 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
97
试验地点
1
主要终点
Number of cyst resolved/ calcified completely after therapy. Resolution or calcification of cyst assessed on CT head at the end of 6 months after starting albendazole

研究概览

简要总结

Comparing the effect of two different duration of same drug albendazole in patients with Neurocysticercosis less than or equal to 5 lesions on CT head at the end of 6 months.

详细描述

The trial will be comparing the effectiveness of short and long duration of albendazole ie 7 and 28 days therapy in patients with parenchymal neurocysticercosis in terms of complete resolution or calcification of cyst on CT head at the end of 6 months after starting albendazole

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 2-18 years.
  • Number of parenchymal lesions: upto 5*
  • Stages of cysticerci at which albendazole treatment is effective
  • Vesicular stage
  • Colloid vesicular stage
  • Granular nodular stage

排除标准

  • Cysticercotic encephalitis
  • Calcified cyst
  • Hydrocephalus
  • Intraventricular cyst
  • Subarachnoid cyst
  • Ophthalmic Cysticercosis
  • No of cysts >5
  • Known allergy to benzimidazole class of compound which includes anaphylaxis, hypotension, severe skin reactions .
  • Features of raised ICT (papilloedema, hyperventilation, hypertension, tonic posturing, B/L 6th nerve palsy, features of midline shift on CT/MRI)
  • Critically sick (respiratory failure, cardiovascular instability)
  • Already received albendazole or praziquantel or steroid therapy

研究组 & 干预措施

Group A

Active Comparator

7 days of albendazole 15 mg/kg/day

干预措施: 7 days of albendazole 15 mg/kg/day (Drug)

Group B

Active Comparator

28 days of albendazole 15 mg/kg/day

干预措施: 28 days of albendazole 15 mg/kg/day (Drug)

结局指标

主要结局

Number of cyst resolved/ calcified completely after therapy. Resolution or calcification of cyst assessed on CT head at the end of 6 months after starting albendazole

时间窗: 1 year

A randomized open labeled control clinical trial to compare the radiological outcome of 7 days versus 28 days albendazole therapy along with steroid in patients with parenchymal neurocysticercosis with lesion load \< 5

次要结局

  • Frequency of seizure occurrence(1 year)
  • Frequency of occurrence of other symptoms attributable to Neurocysticercosis(1 year)
  • Frequency of occurrence of side effects of albendazole(1 year)

研究者

发起方
All India Institute of Medical Sciences, New Delhi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheffali Gulati

Additional professor, dept of Pediatrics

All India Institute of Medical Sciences, New Delhi

研究点 (1)

Loading locations...

相似试验